Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 796

1.

[Hormone replacement therapy and venous thromboembolism].

Pavičić Baldani D, Skrgatić L, Simunić V, Elvedi Gasparović V, Geršak B.

Lijec Vjesn. 2015 Jan-Feb;137(1-2):34-40. Croatian.

PMID:
25906547
2.

Ultrasonographic observation of the breast in early postmenopausal women during therapy with Cimicifuga foetida extract and sequential therapy with estrogen and progestin.

Gaowa S, Sun AJ, Jiang Y, He FW, Zheng TP, Wang YP.

Chin Med J (Engl). 2015 Apr 20;128(8):1000-4. doi: 10.4103/0366-6999.155052.

3.

Practice observed.

Gray S.

Post Reprod Health. 2015 Mar;21(1):37-9. doi: 10.1177/2053369115576632. No abstract available.

PMID:
25802143
4.

What is the influence of hormone therapy on homocysteine and crp levels in postmenopausal women?

Lakryc EM, Machado RB, Soares Jr JM, Fernandes CE 3rd, Baracat EC.

Clinics (Sao Paulo). 2015 Feb;70(2):107-13. doi: 10.6061/clinics/2015(02)07. Erratum in: Clinics (Sao Paulo). 2015 Mar;70(3):228.

5.

Is postmenopausal hormone replacement therapy suitable after a cardio- or cerebrovascular event?

Windler E, Stute P, Ortmann O, Mueck AO.

Arch Gynecol Obstet. 2015 Jan;291(1):213-7. doi: 10.1007/s00404-014-3485-0. Epub 2014 Oct 17.

PMID:
25322975
6.

Molecular modulation of estrogen-induced apoptosis by synthetic progestins in hormone replacement therapy: an insight into the women's health initiative study.

Sweeney EE, Fan P, Jordan VC.

Cancer Res. 2014 Dec 1;74(23):7060-8. doi: 10.1158/0008-5472.CAN-14-1784. Epub 2014 Oct 10.

7.

Hormones and venous thromboembolism among postmenopausal women.

Scarabin PY.

Climacteric. 2014 Dec;17 Suppl 2:34-7. doi: 10.3109/13697137.2014.956717. Epub 2014 Sep 16. Review.

PMID:
25223916
8.

Hemodynamic and metabolic effects of estrogen plus progestin therapy in hypertensive postmenopausal women treated with an ACE-inhibitor or a diuretic.

Posadzy-Malaczynska A, Rajpold K, Woznicka-Leskiewicz L, Marcinkowska J.

Clin Res Cardiol. 2015 Jan;104(1):38-50. doi: 10.1007/s00392-014-0755-6. Epub 2014 Sep 13.

9.

Body mass index, lipid metabolism and estrogens: their impact on coronary heart disease.

Kolovou GD, Kolovou V, Kostakou PM, Mavrogeni S.

Curr Med Chem. 2014;21(30):3455-65. Review.

PMID:
25174916
10.

Menopausal hormone therapy and lung cancer-specific mortality following diagnosis: the California Teachers Study.

Clague J, Reynolds P, Henderson KD, Sullivan-Halley J, Ma H, Lacey JV Jr, Chang S, Delclos GL, Du XL, Forman MR, Bernstein L.

PLoS One. 2014 Jul 31;9(7):e103735. doi: 10.1371/journal.pone.0103735. eCollection 2014.

11.

Arterial imaging outcomes and cardiovascular risk factors in recently menopausal women: a randomized trial.

Harman SM, Black DM, Naftolin F, Brinton EA, Budoff MJ, Cedars MI, Hopkins PN, Lobo RA, Manson JE, Merriam GR, Miller VM, Neal-Perry G, Santoro N, Taylor HS, Vittinghoff E, Yan M, Hodis HN.

Ann Intern Med. 2014 Aug 19;161(4):249-60. doi: 10.7326/M14-0353.

PMID:
25069991
12.

What the future holds for women after menopause: where we have been, where we are, and where we want to go.

Lobo RA.

Climacteric. 2014 Dec;17 Suppl 2:12-7. doi: 10.3109/13697137.2014.944497. Epub 2014 Aug 27.

PMID:
25032478
13.

Hormone therapy and venous thromboembolism among postmenopausal women.

Scarabin PY.

Front Horm Res. 2014;43:21-32. doi: 10.1159/000360554. Epub 2014 Jun 10. Review.

PMID:
24943295
14.

Hormone therapy and hemostasis among postmenopausal women: a review.

Canonico M.

Menopause. 2014 Jul;21(7):753-62. doi: 10.1097/GME.0000000000000296. Review.

PMID:
24937030
15.

Combined estrogen replacement therapy on metabolic control in postmenopausal women with diabetes mellitus.

Xu Y, Lin J, Wang S, Xiong J, Zhu Q.

Kaohsiung J Med Sci. 2014 Jul;30(7):350-61. doi: 10.1016/j.kjms.2014.03.002. Epub 2014 Apr 18. Review.

16.

Menopausal hormone therapy and cancer: changing clinical observations of target site specificity.

Chlebowski RT, Anderson GL.

Steroids. 2014 Nov;90:53-9. doi: 10.1016/j.steroids.2014.06.001. Epub 2014 Jun 6. Review.

18.

Effects of hormone replacement therapy on cerebral serotonin-1A receptor binding in postmenopausal women examined with [carbonyl-¹¹C]WAY-100635.

Kranz GS, Rami-Mark C, Kaufmann U, Baldinger P, Hahn A, Höflich A, Savli M, Stein P, Wadsak W, Mitterhauser M, Winkler D, Lanzenberger R, Kasper S.

Psychoneuroendocrinology. 2014 Jul;45:1-10. doi: 10.1016/j.psyneuen.2014.03.004. Epub 2014 Mar 20.

PMID:
24845171
19.

Is breast cancer risk the same for all progestogens?

Stute P.

Arch Gynecol Obstet. 2014 Aug;290(2):207-9. doi: 10.1007/s00404-014-3270-0.

PMID:
24838289
20.

Insulin resistance and medial prefrontal gyrus metabolism in women receiving hormone therapy.

Rasgon NL, Kenna HA, Wroolie TE, Williams KE, DeMuth BN, Silverman DH.

Psychiatry Res. 2014 Jul 30;223(1):28-36. doi: 10.1016/j.pscychresns.2014.04.004. Epub 2014 Apr 15.

PMID:
24819305
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk